168 related articles for article (PubMed ID: 37337631)
1. JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis.
Li S; Wei Y; Sun X; Liu M; Zhu M; Yuan Y; Zhang J; Dong Y; Hu K; Ma S; Zhang X; Xu B; Jiang H; Gan L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1784-1796. PubMed ID: 37337631
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
3. MSR1 characterized by chromatin accessibility mediates M2 macrophage polarization to promote gastric cancer progression.
Chen X; Jiang J; Liu H; Li A; Wang W; Ni Z; Lin M
Int Immunopharmacol; 2022 Nov; 112():109217. PubMed ID: 36095948
[TBL] [Abstract][Full Text] [Related]
4. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
Shao L; Zhu L; Su R; Yang C; Gao X; Xu Y; Wang H; Guo C; Li H
Sci Rep; 2024 May; 14(1):10745. PubMed ID: 38730240
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells.
Reddi KK; Guruvaiah P; Edwards YJK; Gupta R
Front Oncol; 2022; 12():937831. PubMed ID: 35785205
[TBL] [Abstract][Full Text] [Related]
7. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance.
Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W
Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p.
Wang J; Sun Y; Zhang X; Cai H; Zhang C; Qu H; Liu L; Zhang M; Fu J; Zhang J; Wang J; Zhang G
Cell Death Dis; 2021 Jan; 12(1):90. PubMed ID: 33462197
[TBL] [Abstract][Full Text] [Related]
9. Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells.
Zhang B; Lin J; Zhang J; Wang X; Deng X
Front Cell Dev Biol; 2022; 10():838332. PubMed ID: 35252200
[No Abstract] [Full Text] [Related]
10. TOPBP1 regulates resistance of gastric cancer to oxaliplatin by promoting transcription of PARP1.
Fang Z; Gong C; Ye Z; Wang W; Zhu M; Hu Y; Liu Z; Zhou W; Li H
DNA Repair (Amst); 2022 Mar; 111():103278. PubMed ID: 35124372
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling.
Zhao ZX; Zhang YQ; Sun H; Chen ZQ; Chang JJ; Wang X; Wang X; Tan C; Ni SJ; Weng WW; Zhang M; Wang L; Huang D; Feng Y; Sheng WQ; Xu MD
Acta Pharmacol Sin; 2023 Jan; 44(1):178-188. PubMed ID: 35676532
[TBL] [Abstract][Full Text] [Related]
12. PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer.
Huang W; Han Z; Sun Z; Feng H; Zhao L; Yuan Q; Chen C; Yu S; Hu Y; Yu J; Liu H; Li G; Jiang Y
Cell Death Dis; 2022 Jul; 13(7):658. PubMed ID: 35902562
[TBL] [Abstract][Full Text] [Related]
13. Integrated Chromatin Accessibility and Transcriptome Landscapes of Doxorubicin-Resistant Breast Cancer Cells.
Wang X; Yan J; Shen B; Wei G
Front Cell Dev Biol; 2021; 9():708066. PubMed ID: 34395436
[TBL] [Abstract][Full Text] [Related]
14. CCN2-MAPK-Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma.
Liao X; Bu Y; Jiang S; Chang F; Jia F; Xiao X; Song G; Zhang M; Ning P; Jia Q
Hepatol Int; 2019 Jul; 13(4):440-453. PubMed ID: 31250351
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for advanced gastric cancer.
Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
[TBL] [Abstract][Full Text] [Related]
16. Integration of ATAC-seq and RNA-seq analysis identifies key genes affecting intramuscular fat content in pigs.
Xu Z; Wu J; Zhou J; Zhang Y; Qiao M; Sun H; Li Z; Li L; Chen N; Oyelami FO; Peng X; Mei S
Front Nutr; 2022; 9():1016956. PubMed ID: 36276837
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
[TBL] [Abstract][Full Text] [Related]
18. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
Lin C; Lin P; Yao H; Liu S; Lin X; He R; Teng Z; Zuo X; Li Y; Ye J; Zhu G
Cancer Lett; 2024 Apr; 587():216712. PubMed ID: 38364962
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
[TBL] [Abstract][Full Text] [Related]
20. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
